Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial-Reference-Cited by-同舟云学术

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Published:2017-09 Issue:10101 Volume:390 Page:1499-1510
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Margolis David A,Gonzalez-Garcia Juan,Stellbrink Hans-Jürgen,Eron Joseph J,Yazdanpanah Yazdan,Podzamczer Daniel,Lutz Thomas,Angel Jonathan B,Richmond Gary J,Clotet Bonaventura,Gutierrez Felix,Sloan Louis,Clair Marty St,Murray Miranda,Ford Susan L,Mrus Joseph,Patel Parul,Crauwels Herta,Griffith Sandy K,Sutton Kenneth C,Dorey David,Smith Kimberly Y,Williams Peter E,Spreen William R

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Progress report 2016: prevent HIV, test and treat all,2016

2. The survival benefits of AIDS treatment in the United States;Walensky;J Infect Dis,2006

3. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis;Blanc;N Engl J Med,2011

4. Asking about adherence: from flipping the coin to strong evidence;Glass;Swiss Med Wkly,2014

5. Long-acting antiviral agents for HIV treatment;Margolis;Curr Opin HIV AIDS,2015

Cited by 404 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of switching to injectables cabotegravir and rilpivirine on sleep disturbances in a cohort of people living with HIV;HIV RES CLIN PRACT;2024

2. Pittsburgh Sleep Quality Index (PSQI) Changes in Virologically Suppressed People Living with HIVSwitching to Long-Acting Cabotegravir and Rilpivirine;Biomedicines;2024-09-02

3. Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective;Molecular Pharmaceutics;2024-08-19

4. Cabotegravir (Vocabria): An HIV Integrase Strand Transfer Inhibitor for Treating HIV Infection;Chemistry and Pharmacology of Drug Discovery;2024-08-16

5. Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South;AIDS Research and Human Retroviruses;2024-07-16